A Study of the Absorption, Metabolism, and Excretion of Tucatinib in Healthy Participants

NCT03758339 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
8
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Cascadian Therapeutics Inc.